Verisante Technology Inc. V.VRS

Primary Symbol: V.VER.H

Healthcare

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.

TSXV:VER.H - Post by User

Verisante Technology Inc.

Bullboard Posts

Comment by firesIayer96on Aug 09, 2013 6:41pm

435 Views

Post# 21660630

RE:RE:RE:RE:Proteo Monitor report

MT, as per SLs reply.

Also, seeing as you asked about the statistical analysis. The numbers should be fairly predictable, based on the pilot and intermediate numbers peviously announced. They are:

The pilot lung study (129 sites) showed 96% sensitivity and 91% specificity.
The expanded lung site measurements (267 sites) announced late 2012 show 91.3% sensitivity and 82.3% specificity.
My guess is that the completed full site analysis (300+ sites) will show numbers similar to the 267 site data analysis.

Also, its nice to see that the colon clinical study led by Dr. Tai is underway. Colon cancer is another cancer where survival rates increase significantly with early detection. Perhaps the Core will become that early detection standard for colon cancer too!

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”